Details for 2015798264

Up to date per 03.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE GEGEN KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015798264

EP Publication Number

3212670

E-Number

1347647

Language

PCT Number

US15057781

Publication Date

06.09.2017 A

23.12.2020 B1

Registration Date

23.12.2020

AT Publication Date

15.01.2021

Application Date

28.10.2015

Registration Number

Priorities

29.10.2014

201462072035 P

05.05.2015

201562157368 P

13.07.2015

201562192025 P

IPC

C07K 16/28 20060101AFI20160512BHEP

Maximum Duration of Protection

28.10.2035

Owner

Five Prime Therapeutics, Inc.111 Oyster Point Boulevard South San Francisco, CA 94080US

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

WONG, BrianTwo Corporate Drive South San Francisco, California 94080US

HAMBLETON, JulieTwo Corporate Drive South San Francisco, California 94080US

SIKORSKI, RobertTwo Corporate Drive South San Francisco, California 94080US

MASTELLER, EmmaTwo Corporate Drive South San Francisco, California 94080US

HESTIR, KevinTwo Corporate Drive South San Francisco, California 94080US

BELLOVIN, DavidTwo Corporate Drive South San Francisco, California 94080US

LEWIS, Katherine E.Rt. 206&Province Line Road Princeton, New Jersey 08543US